Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Del Pharmaceuticals' Orajel

This article was originally published in The Tan Sheet

Executive Summary

Del Pharmaceuticals' Orajel: New Perioseptic Super Cleaning Oral Rinse, with 1.5% hydrogen peroxide in solution containing 4% ethyl alcohol, is entering full distribution in pharmacies, food and mass merchandise outlets after shipping began at end of September, Del said. Del also is reintroducing existing Orajel Perioseptic liquid product as Orajel Perioseptic Spot Treatment Oral Cleanser with carbamide peroxide 15%. Both products are labeled for cleansing localized sore spots due to denture irritation, canker sores, dental procedures, orthodontic appliances, injury or gum irritation. The rinse also aids in removal of phlegm, mucus and "other secretions associated with occasional sore mouth," labeling claims. The rinse is formulated "to supplement...regular mouthwash routine" and to promote "natural healing." A promotional campaign, still in development, will feature print ads in consumer magazines and professional dental publications...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel